TradingMarkets’ 10 Stocks You Need To Know About This Morning
Monsanto
(
MON |
Quote |
Chart |
News |
PowerRating) may benefit from less resistance to its genetically
altered seeds, says Barron’s.
Kimberly Clark
(
KMB |
Quote |
Chart |
News |
PowerRating) guided in-line, said it would buy back $1
billion in shares, and increased its dividend.
Navistar
(
NAV |
Quote |
Chart |
News |
PowerRating) boosted its Q4 outlook.
Circuit City
(
CC |
Quote |
Chart |
News |
PowerRating) said same store sales fell 4.3%; expectations
were +2.6%.
Celgene
(
CELG |
Quote |
Chart |
News |
PowerRating) reported positive data for several studies.
Corgentech
(
CGTK |
Quote |
Chart |
News |
PowerRating) is lower after an experimental product failed a
late stage trial. Bristol Myers
(
BMY |
Quote |
Chart |
News |
PowerRating) is also involved in this trial.
Callaway Golf
(
ELY |
Quote |
Chart |
News |
PowerRating) was mentioned positively in Barron’s.
Unocal
(
UCL |
Quote |
Chart |
News |
PowerRating) said its board authorized a $465 million buyback.
Barron’s said Cato Corp.
(
CATO |
Quote |
Chart |
News |
PowerRating) may be undervalued.